U10 CA035195/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	1
2008	9
2009	14
2010	25
2011	13
2012	9
2013	5
2014	7
2015	2
2016	2
2017	1
2018	1
2021	2
2024	0

1

Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose.

Niska JR, Hu J, Li J, Herman MG, Thorpe CS, Schild SE, Fatyga M. Niska JR, et al. J Cancer Ther. 2021 Sep;12(9):505-529. doi: 10.4236/jct.2021.129044. Epub 2021 Sep 29. J Cancer Ther. 2021. PMID: 34804634 Free PMC article.

2

Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC).

Anderson JD, Hu J, Li J, Schild SE, Fatyga M. Anderson JD, et al. J Cancer Ther. 2021 Jul;12(7):409-423. doi: 10.4236/jct.2021.127036. J Cancer Ther. 2021. PMID: 34367717 Free PMC article.

3

Modeling of Acute Rectal Toxicity to Compare Two Patient Positioning Methods for Prostate Cancer Radiotherapy: Can Toxicity Modeling be Used for Quality Assurance?

Liu X, Li J, Schild SE, Schild MH, Wong W, Vora S, Herman MG, Fatyga M. Liu X, et al. OMICS J Radiol. 2018;7(5):302. doi: 10.4172/2167-7964.1000302. Epub 2018 Dec 3. OMICS J Radiol. 2018. PMID: 30775161 Free PMC article.

4

Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy.

Liu X, Li J, Schild SE, Schild MH, Wong W, Vora S, Herman MG, Fatyga M. Liu X, et al. J Cancer Ther. 2017 Feb;8(2):73-85. doi: 10.4236/jct.2017.82007. Epub 2017 Feb 6. J Cancer Ther. 2017. PMID: 28239505 Free PMC article.

5

Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade ≥ 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers.

Liu X, Li J, Wu T, Schild SE, Schild MH, Wong W, Vora S, Fatyga M. Liu X, et al. OMICS J Radiol. 2016 Jun;5(3):225. doi: 10.4172/2167-7964.1000225. Epub 2016 Jun 13. OMICS J Radiol. 2016. PMID: 27478689 Free PMC article.

6

Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).

Sio TT, Atherton PJ, Birckhead BJ, Schwartz DJ, Sloan JA, Seisler DK, Martenson JA, Loprinzi CL, Griffin PC, Morton RF, Anders JC, Stoffel TJ, Haselow RE, Mowat RB, Wittich MA, Bearden JD 3rd, Miller RC. Sio TT, et al. Support Care Cancer. 2016 Sep;24(9):3847-55. doi: 10.1007/s00520-016-3213-3. Epub 2016 Apr 14. Support Care Cancer. 2016. PMID: 27075674 Free PMC article. Clinical Trial.

7

Early Outcome of Prostate Intensity Modulated Radiation Therapy (IMRT) Incorporating a Simultaneous Intra-Prostatic MRI Directed Boost.

Schild MH, Schild SE, Wong WW, Vora SA, Silva AC, Silva AM, Daniels TB, Keole SR. Schild MH, et al. OMICS J Radiol. 2014 Dec;3(4):170. doi: 10.4172/2167-7964.1000170. OMICS J Radiol. 2014. PMID: 25717423 Free PMC article.

8

North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.

Park H, Qin R, Smith TJ, Atherton PJ, Barton DL, Sturtz K, Dakhil SR, Anderson DM, Flynn K, Puttabasavaiah S, Le-Lindqwister NA, Padula GD, Loprinzi CL. Park H, et al. Menopause. 2015 Jun;22(6):627-32. doi: 10.1097/GME.0000000000000374. Menopause. 2015. PMID: 25423327 Free PMC article. Clinical Trial.

9

A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321.

Zhao Y, Foster NR, Meyers JP, Thomas SP, Northfelt DW, Rowland KM Jr, Mattar BI, Johnson DB, Molina JR, Mandrekar SJ, Schild SE, Bearden JD 3rd, Aubry MC, Adjei AA. Zhao Y, et al. J Thorac Oncol. 2015 Jan;10(1):172-80. doi: 10.1097/JTO.0000000000000383. J Thorac Oncol. 2015. PMID: 25247339 Free PMC article. Clinical Trial.

10

Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).

Barton DL, Thanarajasingam G, Sloan JA, Diekmann B, Fuloria J, Kottschade LA, Lyss AP, Jaslowski AJ, Mazurczak MA, Blair SC, Terstriep S, Loprinzi CL. Barton DL, et al. Cancer. 2014 Nov 15;120(22):3575-83. doi: 10.1002/cncr.28892. Epub 2014 Jul 9. Cancer. 2014. PMID: 25043153 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

71 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year